in islet transplantation
Sernova Pouch Study
Now, Open enrollment!
Allotransplantation for patients with T1DM
A Safety, Tolerability and Efficacy Study of Sernova’s Cell Pouch™ for Clinical Islet Transplantation.
Funded by JDRF/Sernova
I am writing to let you know about an opportunity to participate in a research study designed for patients with "brittle" form of Type 1 Diabetes. I am a Principal Investigator for this single center study carried out here, at the University of Chicago.
This research study will assess the safety, tolerability and efficacy of the Sernova Cell Pouch™ that will be implanted under the skin within your abdominal muscles and transplanted with human pancreatic islets.
You may be eligible for this study if:
you are between the ages of 18-65,
have been diagnosed with Type 1 Diabetes for longer than 5 years,
suffer from sudden and unpredictable drops of blood glucose leading to confusion or passing out despite the best medical treatment of insulin under the guidance of an experienced diabetologist.
If you are interested in learning more about this study, please review Brief description. For your convenience, you also print the entire Patient information package. On the separate page you will find also information
how to enroll : Enroll Here and then contact our Research Manager Lindsay Basto, RN, MSN,
Lindsay.Basto@uchicago.edu or 773-702-2504 for any additional instructions.
It is important to know that this letter is not to tell you to join the study.
It is your decision, and your participation is voluntary.
Whether you show interest, and participate in the study or not, it will have no effect on your treatment with your doctors.
Thank you for your interest and consideration,
Piotr Witkowski M.D. Ph.D